Watch IART. Know when insiders buy.
One email the day a filing lands. Free.
IART
INTEGRA LIFESCIENCES HOLDINGS CORP
12.14
−1.19 −8.93%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
46
WATCH · shorts 46
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $944.2MP/E —DIV YIELD —FCF YIELD 2.73%REV TTM $1.6B +1.6%NET INCOME −$7.2MNET DEBT $492.8M52W 8.90 – 19.85SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $418.8M | +0.8% | 52.5% | $19.3M | $4.5M | — | 0.06 | $22.8M | $12.3M | $10.5M | Jul 29 |
| Q1 2026 · Mar 31 | $391.9M | +2.4% | 55.4% | $11.5M | −$4.6M | — | -0.06 | $9.8M | $14.8M | −$5M | Jul 29 |
| Q4 2025 · Dec 31derived | $434.9M | −1.7% | 50.8% | $23M | −$1.7M | −108.8% | -0.02 | $11.8M | $17.2M | −$5.4M | Feb 26 |
| Q3 2025 · Sep 30 | $402.1M | +5.6% | 51.5% | $11.8M | −$5.4M | — | -0.07 | $40.9M | $15.2M | $25.8M | Oct 30 |
| Q2 2025 · Jun 30 | $415.6M | −0.6% | 50.4% | −$512.7M | −$484.1M | — | -6.31 | $8.9M | $20.1M | −$11.2M | Jul 29 |
| Q1 2025 · Mar 31 | $382.7M | +3.7% | 50.8% | −$15.5M | −$25.3M | — | -0.33 | −$11.3M | $28.9M | −$40.2M | Jul 29 |
| Q4 2024 · Dec 31derived | $442.6M | +11.5% | 56.3% | $35.6M | $19.4M | −2.0% | 0.25 | $50.7M | $29.6M | $21.1M | Feb 26 |
| Q3 2024 · Sep 30 | $380.8M | −0.4% | 52.6% | −$8.2M | −$10.7M | −154.9% | -0.14 | $22.5M | $29.6M | −$7.2M | Oct 30 |
| Q2 2024 · Jun 30 | $418.2M | — | 54.0% | −$3M | −$12.4M | — | -0.16 | $40.4M | $29.7M | $10.7M | Oct 30 |
| Q1 2024 · Mar 31 | $368.9M | — | 56.1% | $4M | −$3.3M | — | -0.04 | $15.8M | $15.5M | $291K | Oct 30 |
| Q4 2023 · Dec 31derived | $397M | — | 57.0% | $36M | $19.8M | — | 0.25 | $58.8M | $24.5M | $34.2M | Feb 26 |
| Q3 2023 · Sep 30 | $382.4M | — | 57.1% | $26.6M | $19.5M | — | 0.24 | $26.8M | $13.1M | $13.7M | Nov 4 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $1.6B | 50.9% | −$493.4M | −$516.5M | -31.6% | -6.74 | $50.4M | $81.4M | −$31.1M | $221K | — |
| FY2024 · to Dec 31 | $1.6B | 54.8% | $28.4M | −$6.9M | -0.4% | -0.09 | $129.4M | $104.4M | $25M | $52.5M | — |
| FY2023 · to Dec 31 | $1.5B | 57.4% | $111.5M | $67.7M | 4.4% | 0.84 | $140M | $66.9M | $73.1M | $275M | — |
| FY2022 · to Dec 31 | $1.6B | 62.3% | $238.9M | $180.6M | 11.6% | 2.16 | $264.5M | $42.3M | $222.1M | $125M | — |
| FY2021 · to Dec 31 | $1.5B | 61.2% | $197.2M | $169.1M | 11.0% | 1.98 | $312.4M | $48M | $264.4M | $0 | — |
| FY2020 · to Dec 31 | $1.4B | 62.0% | $151.4M | $133.9M | 9.8% | 1.57 | $203.8M | $38.9M | $164.9M | $100M | — |
Every number comes from INTEGRA LIFESCIENCES HOLDINGS CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.